- Imricor

Our Products
About Us
Newsroom
- Events
Investors
Patients
Contact

lukeMay 17, 2024

Distribution Agreement with Regional Health Care Group, Expanding Reach to Australia and New Zealand

Recent News

Johns Hopkins Treats First Patient in the United States as Part of Imricor’s VISABL-AFL Clinical Trial
VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris
Imricor Receives Approval from Saudi Food and Drug Authority

Contact Us

Name*
First Last
Title
Hospital Affiliation
Email*
Phone
City
Country
Message
CAPTCHA

© 2024 Imricor
All Rights Reserved.

Our Products

Vision-MR Ablation Catheter
Advantage-MR EP Recorder / Stimulator
Additional Products

Quick Links

About Us
Newsroom
Investors
Events
Careers
Warranty
Contact Us

Site by Hafi Design & Tela

Our Products

Vision-MR Ablation Catheter
Advantage-MR EP Recorder / Stimulator
Additional Products

Quick Links

About Us
Newsroom
Investors
Events
Careers
Warranty
Contact Us

Site by L. Finsaas Design & Tela.

Caution: The Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter, and Vision-MR Dispersive Electrode have received CE mark approval and have not yet been approved for use in the United States.

Our Products
About Us
Newsroom
- Events
Investors
Patients
Contact